What is the latest price of filgotinib in 2025?

Filgotinib (Filgotinib) is indicated for the treatment of active moderate to severe rheumatoid arthritis alone or in combination with methotrexate. Filgotinib is currently used in patients who cannot tolerate or have an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDS). Filgotinib is also used to treat moderately to severely active ulcerative colitis in adults who have had an inadequate response, loss of response, or intolerance to conventional therapies or biologic agents. Rheumatoid arthritis is a disease in which the body's immune system attacks healthy tissue, causing joint inflammation and pain.

The active substance in filgotinibfilgotinib acts on an enzyme called Janus kinase (JAK). Filgotinib blocks the action of a specific isoform of JAK1. These enzymes play an important role in the inflammatory process of rheumatoid arthritis. By blocking the action of JAK1, filgotinib helps reduce inflammation and other symptoms of RA. It helps reduce pain, fatigue, stiffness and joint swelling. It slows down damage to bones and cartilage in joints.

Figotinib is taken orally once daily at 200 mg (tablet); patients can only start treatment with filgotinib if blood levels of hemoglobin and certain white blood cells are above set limits. If blood levels fall below this limit, treatment may be interrupted.

The original drug filgotinib has not yet been launched in China, so it is not included in medical insurance, and the domestic price is not yet clear. The European version of filgotinib currently on the market overseas, with specifications200mg*30 tablets, may cost more than 10,000 yuan per box. There are also generic versions of this drug sold overseas, and the ingredients are basically the same as those of the original drug. For example, the price of a box of 100mg*30 tablets produced by a Laos pharmaceutical factory may be more than 1,000 yuan (the price may fluctuate due to the exchange rate). For more drug information and specific prices, please consult Yaode Medical Consultant.

Reference materials:https://go.drugbank.com/drugs/DB14845